Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism
- 1 November 1991
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 91 (5) , 507-511
- https://doi.org/10.1016/0002-9343(91)90187-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- AMIODARONE AND THYROID HORMONE ACTION JAYNE A.Clinical Endocrinology, 1985
- Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.Circulation, 1983
- Amiodarone in Refractory Life-Threatening Ventricular ArrhythmiasAnnals of Internal Medicine, 1983
- Are Selective Increases in Serum Thyroxine (T4)due to Iodinated Inhibitors of T4Monodeiodination Indicative of Hyperthyroidism?*Journal of Clinical Endocrinology & Metabolism, 1982
- Hyperthyroxinemia with Bradycardia and Normal Thyrotropin Secretion after Chronic Amiodarone Administration*Journal of Clinical Endocrinology & Metabolism, 1981
- AmiodaroneNew England Journal of Medicine, 1981
- Pharmacokinetics of amiodarone after intravenous and oral administrationEuropean Journal of Clinical Pharmacology, 1981
- ‘LOW T3 SYNDROME’ IN PATIENTS CHRONICALLY TREATED WITH AN IODINE-CONTAINING DRUG, AMIODARONEClinical Endocrinology, 1978
- Clinical efficacy of amiodarone as an antiarrhythmic agentThe American Journal of Cardiology, 1976
- Effects of amiodarone on thyroid function in patients with ischaemic heart disease.Heart, 1975